Pacer Advisors Inc. cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 97.5% in the first quarter, Holdings Channel reports. Pacer Advisors Inc.’s holdings in BioMarin Pharmaceutical were worth $1,336,000 at the end of the most recent reporting period. Get BioMarin Pharmaceutical alerts:Trending Headlines about BioMarin PharmaceuticalHere are the key news stories impacting BioMarin Pharmaceutical this week:Positive Sentiment: Q2 results exceeded expectations. BioMarin Axes Rare-Disease AssetBioMarin Pharmaceutical Stock PerformanceBioMarin Pharmaceutical stock opened at $63.81 on Friday. Receive News & Ratings for BioMarin Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioMarin Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.